Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Large Molecule
Sort By
Newest First
1 / 13
1 / 13
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38
Oct 11, 2024
The PHASE Platform
How Synergistic Collaborations Between Outsourcing Partners Can Accelerate Clinical Success
Wheeler Bio
PAO-05-24-CL-01
May 08, 2024
Outsourced Manufacturing
A Closer Look at Small Molecule Drug Substance and Drug Product Manufacturing
April Stanley, MS MBA
Nice Insight
PAO-03-24-NI-02
Mar 27, 2024
Analytical Method Development
Harnessing Biologic Development Experience in Support of CDMO Clients: Rapid, Effective and Tailored Analytical Method Development
Xuemei Han, Ph.D.
Tanvex CDMO
PAO-03-24-CL-09
Mar 13, 2024
Bispecific Antibodies
Accelerating the Development and Production of High-Quality Bispecific Antibodies
Dongyoung Park
Samsung Biologics
PAO-03-24-CL-01
Mar 04, 2024
Biologics Formulation
Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform
Pawel Stanczak, Ph.D.
Tanvex CDMO
PAO-02-24-CL-02
Feb 15, 2024
Recombinant Antibody
Recombinant Antibody Technology is Crucial to Past and Future Success in Biopharma
Suranjana Sen, Ph.D.
Sino Biological
PAO-01-24-CL-4
Jan 24, 2024
Glycosylation
S-Glyn™ : Optimizing N-Glycan Profiles and their Effector Functions Using a Design-of-Experiments Approach
Junyong Park
Samsung Biologics
PAO-12-23-CL-06
Dec 14, 2023
Strategic Partnership
Samsung Biologics and Kurma Partners Announce Strategic Partnership for Development and Manufacturing of Biologics for Kurma’s Portfolio Companies
Samsung Biologics
PR-M10-23-06
Oct 24, 2023
Insect Cell Expression
Innovations in Baculovirus–Insect Cell Expression Systems
Amy Sheng, Ph.D.; Yingmin Zhu, Ph.D.; Xuejiao Zhang, Ph.D.
Sino Biological
PAO-09-23-CL-01
Aug 31, 2023
Quality Culture
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne
Scorpius BioManufacturing
PAO-07-23-CL-07
Jul 27, 2023
R&D
Integrating Digital Solutions to Streamline Biopharma Operations
Christian Olsen
Dotmatics
PAO-07-23-CL-06
Jul 17, 2023
Leadership
Wheeler Bio Appoints Dr. Stewart McNaull as Chief Business Officer
Wheeler Bio
PR-M06-23-02
Jun 06, 2023
Distribution
Redefining Innovation and Growth in Pharmaceutical Distribution
Ernest de Freitas
Univar Solutions
PAO-06-23-CL-03
Jun 06, 2023
Biomanufacturing
Biologics Outsourcing: Decision Drivers and Key Considerations
Scorpius BioManufacturing
PAO-04-23-CL-01
Apr 18, 2023
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Gil Efron
Purple Biotech
PAO-03-23-CL-01
Mar 21, 2023
Scale-Up
Scale-Up Expertise to Support Your Biologics Life Cycle
Pramthesh (Prem) Patel, Ph.D.
Avid Bioservices
PAO-02-23-CL-06
Mar 02, 2023
Antibody Production
From Llamas to Yeast: Producing Functional Therapeutic Antibody Fragments in Saccharomyces cerevisiae
Phenotypeca
PAO-01-23-CL-05-153
Feb 01, 2023
Biomanufacturing
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Scorpius BioManufacturing
PAO-01-23-CL-04
Jan 31, 2023
Anti-Idiotype Antibodies
Rapid Supply of Anti-Idiotype Antibodies Facilitates Preclinical and Clinical Antibody-Based Drug Development
Na Li, Ph.D.
Sino Biological
PAO-01-23-CL-01
Jan 13, 2023
